At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 20 enrolled
Drug / intervention
Premarindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·interventional·Posted Apr 26, 2006·Updated Jul 9, 2009
In Brief
A Phase 1 clinical trial evaluating Premarin for Healthy and Estrogen Replacement Therapy. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the immunological status of patients using Premarin. Premarin use is associated with an enhanced immune status, and possibly even some anti-cancer effect. The researchers will compare the use of Premarin with those not using hormone replacement therapy (HRT) to track the effects of Premarin in reducing the risk of infection and swelling.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Estrogen Replacement Therapy
CountriesCanada
Collaborators--
Timeline
Phase 1CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2006
First PostedApr 2006
Primary CompletionDec 2006
Study CompletionFeb 2007
TodayJul 2026
First PostedApr 26, 2006
Enrollment StartMar 1, 2006
Primary CompletionDec 1, 2006
Study CompletionFeb 1, 2007
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 20.2 years ago
Interventions
Premarindrug